Mirum Pharmaceuticals Inc (MIRM) returns
Mirum Pharmaceuticals returns over 5 years
$1,000 invested in Mirum Pharmaceuticals five years ago was worth $5,353 at the close on October 30, 2026, with dividends reinvested: an average return of 39.9% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -0.6% | — | $994.39 | -0.9% |
| 3 months | -24.5% | — | $754.95 | +2.1% |
| Year to date | +7.6% | — | $1,076 | +11.7% |
| 1 year | +17.7% | — | $1,177 | +12.4% |
| 3 years | +211.9% | +46.1% | $3,119 | +88.5% |
| 5 years | +435.3% | +39.9% | $5,353 | +76.0% |
Mirum Pharmaceuticals return by calendar year
| Year | MIRM | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +7.6% | +11.7% | -4.1% |
| 2025 | +91.0% | +17.7% | +73.3% |
| 2024 | +40.1% | +24.9% | +15.2% |
| 2023 | +51.4% | +26.2% | +25.2% |
| 2022 | +22.3% | -18.2% | +40.4% |
| 2021 | -8.6% | +28.7% | -37.4% |
| 2020 | -28.8% | +18.4% | -47.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: MIRM financials
No forecast, no recommendation. This page describes Mirum Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.